Related Experiment Video
Updated: May 21, 2026
09:36
Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Mouse models in arrhythmogenic right ventricular cardiomyopathy
Elisabeth M Lodder1, Stefania Rizzo
1Department of Experimental Cardiology, Heart Failure Research Center, Academic Medical Center, University of Amsterdam Amsterdam, Netherlands.
Frontiers in Physiology
|June 28, 2012
Summary
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart condition caused by faulty cell adhesion. This review discusses mouse models used to understand how gene mutations lead to ARVC.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disorder.
- It is characterized by fibro-fatty replacement of heart muscle cells, leading to arrhythmias and sudden cardiac death.
- Mutations in desmosomal proteins, crucial for cell adhesion, are implicated in ARVC pathogenesis.
Purpose of the Study:
- To review the mechanisms underlying ARVC.
- To discuss the development and findings of transgenic and targeted mouse models for ARVC research.
- To elucidate how desmosomal protein mutations cause fibro-fatty replacement in the heart.
Main Methods:
- Review of scientific literature on ARVC.
- Analysis of data from various transgenic and targeted mouse models developed over the last 10 years.
- Discussion of the insights gained from these animal models.
Main Results:
- Mouse models have been instrumental in studying ARVC.
- These models help investigate the link between desmosomal dysfunction and cardiac pathology.
- Insights into ARVC pathogenesis are being uncovered through these models.
Conclusions:
- ARVC is fundamentally a disease of abnormal cell-cell adhesion.
- Mouse models are crucial tools for understanding ARVC mechanisms.
- Further research using these models is needed to fully elucidate ARVC pathogenesis.
